A young Dublin woman is appealing to the HSE after they refused to give her a new cancer drug that could save her life.

At €100,000 per patient, per year, the health authority has said Nivolumab, known as Opdivo, is too expensive.

But 34-year-old Jacinta Kelleher says it’s her only chance of surviving Kidney cancer.

Since her diagnosis three years ago she has endured numerous operations to remove tumours – resulting in the loss of one of her kidneys.

Jacinta says this new drug is her last chance: “It is a lot of money but at the same time, this is my life.

“It is not something stupid, it is not a broken arm that you could easily fix, this will kill me and I am 34-years of age, I haven’t even begun to live my adult life yet.

“And my husband doesn’t deserve to be a widower at 34, 35 years of age.”